Company Intelligence Profile
Novocura Tech Health Services Private Limited
Novocura Tech Health Services Private Limited is the corporate entity behind mfine, an AI-enabled digital healthcare / telemedicine platform founded in 2017 by Prasad Kompalli and Ashutosh Lawania, offering instant doctor teleconsultations, at-home diagnostic lab tests, medicine delivery, dental/vision care and chroni…
Last updated 10 August 2026
Novocura Tech Health Services Private Limited operates the AI-enabled digital healthcare platform mfine, providing telemedicine services, at-home diagnostics, and more. Founded in 2017, it merged with LifeCell International's diagnostics business in 2022 to form LifeWell, supported by an $80M investment from OrbiMed. Financial reporting for FY2025 showed a 64% revenue decline, reflecting a post-merger restructuring.
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Unlock the full profile on AICA
Deeper analysis, financial signals and peer comparisons.
Company Identity
| Registered name | Novocura Tech Health Services Private Limited |
|---|---|
| CIN | U85100TN2017PTC166713 |
| PAN | AAFCN4953K |
| Status | Active |
| Listing | Unlisted (private limited company; not listed on any stock exchange) |
| Incorporated | 16 February 2017 |
| ROC | RoC Chennai / Tamil Nadu |
| Sector (NIC) |
|
| Registered address |
|
| Authorized capital | ₹19.53 crore |
| Paid-up capital | ₹18.59 crore |
Business Overview
- Novocura Tech Health Services Private Limited is the corporate entity behind mfine, an AI-enabled digital healthcare / telemedicine platform founded in 2017 by Prasad Kompalli and Ashutosh Lawania, offering instant doctor teleconsultations, at-home diagnostic lab tests, medicine delivery, dental/vision care and chronic-disease-management programs to consumers and corporates (clients cited on mfine.co include Amazon, Honeywell, Nestlé, Uber, American Express)
- In July 2022, mfine merged with LifeCell International's diagnostics business to form a combined entity (reported as "LifeWell"), with OrbiMed investing $80M in the merged unit
- This explains the shared registered address with LifeCell International and the multiple common-director links to LifeCell-group entities found on Tofler (LifeCell International, LifeWell Diagnostics, Cellutions Biostorage, H S Pathology, Creative Art Concepts, Abusha Estates, Amuda Capital Services LLP)
- Financial filings for FY2025 show a sharp (~64%) YoY revenue decline and near-elimination of borrowings/net-worth, consistent with a post-merger wind-down/restructuring of the standalone mfine legal entity rather than a going-concern operating business at prior scale
- Confidence: medium — the merger narrative is corroborated by two independent aggregator/press mentions but full primary-filing confirmation was not obtained
Directors
Confirmed from Tofler/TheCompanyCheck (2 sources agree on names, DINs only partially sourced):
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Ashutosh Lawania | 01295011 | Director | 16-Feb-2017 |
Financials
Novocura Tech Health Services experienced a significant drop in revenue to ₹18.85 crore in FY2025, down approximately 64% year-on-year, with borrowings eliminated and total assets reducing by about 85%. Despite these declines, the company achieved an impressive operating margin of 98.46% and a net profit margin of 4.12%.
- FY2025 (audited, standalone, year ending March 2025) — TheCompanyCheck: Revenue ₹18.85 crore (down ~64% YoY)
- Tofler (same filing): revenue bracket "₹10-25 crore", borrowings down 100% (eliminated), total assets down ~85%, book net worth down ~238% (i.e., swung deeply negative), operating margin 98.46%, net profit margin 4.12%, gross margin 0.08%, ROCE 225.75%, debt-to-equity 1.18
- EBITDA and absolute PAT/net-worth/borrowings figures are paywalled on both aggregators — not obtained as exact values
- Two sources agree directionally (large YoY decline) — confirmed trend, unconfirmed exact absolute figures
- This pattern is consistent with the July 2022 mfine/LifeCell merger reshaping the standalone entity's books; standalone vs. consolidated treatment for the merged "LifeWell" entity is unclear and not separately confirmed
Funding
Funding raised is attributed to the mfine brand/business (pre-merger), not confirmed as filed directly against this CIN in primary MCA records:
| Series A, May 2018 | $4.2M |
|---|---|
| Series B | $17.2M, lead SBI Investment (Japan), with SBI Ven Capital, Beenext, Stellaris Venture Partners, Prime Venture Partners |
| Later round, 31-May-2021 | $48M, led by Beenext, with SBI Group Japan, Stellaris Venture Partners, Heritas Capital, SBI Ven Capital Singapore, Y's Investment, Prime Venture Partners, Alteria Capital |
| Total raised | Tracxn and TheCompanyCheck agree on ~$87.7M across 9 rounds/30 investors. Inc42 Datalabs reportedly shows "$592.99M+" — this figure is a strong outlier and very likely conflates mfine with the larger combined LifeCell/LifeWell group's cumulative funding (an entity-confusion risk flagged per house rules); NOT used as the headline number |
| Post-merger | OrbiMed invested $80M into the combined mfine+LifeCell diagnostics entity ("LifeWell") in/around July 2022 — this capital sits at the merged-entity level, not confirmed as booked directly under this CIN |
Tracxn used here only for round names/amounts per house rules, cross-checked against press (Inventiva, AsiaTechDaily, Entrackr).
Charges/Loans
- 0 open charges
- 3 satisfied charges totaling ₹46 crore — ₹6 crore (10-Oct-2018), ₹25 crore (14-Jun-2019), ₹15 crore (21-Jan-2021), all marked satisfied
- TheCompanyCheck corroborates "no registered (open) charges." Confirmed
Legal
One case found on Indian Kanoon: "M/S Avanta Solutions Business Centre vs M/S Novocura Tech Health Services Private Limited," Delhi High Court, heard by Justice Subramonium Prasad, dated 21 May 2026.
Competitors
Frequently Asked Questions
What does Novocura Tech Health Services Private Limited do?
What is the CIN of Novocura Tech Health Services Private Limited?
Where is Novocura Tech Health Services Private Limited registered?
When was Novocura Tech Health Services Private Limited incorporated?
Recur Market
Which lenders fit a company like Novocura Tech Health Services Private Limited?
Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.
Explore on Recur Club
More from Recur Club
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.